01
Lead program · Molecular imaging
⁶⁴Cu–MOL-Q131b
Molecular imaging program designed to visualize inflammation-associated biology in vivo.
Preclinical research
Engineering biology across molecular form, tissue and time.
Precision biology for inflammatory disease and solid tumors.
MOLTHERA develops purpose-built biologics, molecular imaging agents and localized delivery systems to reveal complex disease biology and intervene with greater precision.
Portfolio5 proprietary programsAcross four complementary capabilities
Capability⬡Inflammation targetingCapability◌Molecular imagingCapability◇Matrix biologyCapability◎Local deliveryOur approach / 01
Build the molecule.
Map the biology.
Localize the effect.
Complex disease biology changes with molecular form, cellular context, location and time. MOLTHERA integrates protein engineering, molecular imaging and localized delivery to distinguish these dimensions—and translate biological insight into differentiated programs.
Development portfolio / 02
Five programs. One integrated strategy.
MOLTHERA’s programs are supported by proprietary molecular designs, active development work, and a growing body of analytical, functional, and translational evidence. Program profiles and development plans will evolve as validation advances.
02
Dual-pathway biologic · Therapeutic
MOL-Q144a
Purpose-built biologic designed to modulate complementary inflammatory pathways within complex disease microenvironments.
Candidate characterization
03
Selective inflammation biologic · Therapeutic
MOL-Q131a
Long-acting biologic designed for selective modulation of soluble inflammatory signaling.
Preclinical research
04
Matrix engineering · Enzyme platform
MOL-H159x
Hyaluronidase platform engineered for controlled conjugation and conditional activity within diseased tissue.
Platform feasibility
05
Localized delivery · Implant platform
ImmunoRod™
Biodegradable intratumoral implant designed to deliver biologics over a controlled, rapid-release interval—creating a defined therapeutic intervention window in solid tumors.
Discovery
Scientific thesis / 03
Inflammation is not one signal. Our tools are not one-dimensional.
Inflammatory biology is shaped by molecular form, cellular context, tissue architecture and time. MOLTHERA develops programs that reveal these dimensions and use them to guide more precise intervention.
01Selective biology
Biologics engineered around defined mechanistic hypotheses.
02Spatial insight
Molecular imaging designed to connect biological activity with disease location.
03Intervention window
Localized delivery designed to control where and when biologic activity occurs.
Company / 04
Built to translate complex biology into differentiated programs.
MOLTHERA is an emerging biotechnology company advancing a proprietary portfolio of biologics, molecular imaging agents and localized delivery platforms for inflammatory disease and oncology.
Start a confidential conversation ↗